Large review finds no clinically important effect of glucosamine or chondroitin on pain in people with osteoarthritis of the knee or hip but results are questionable and likely due to heterogeneity
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests OB has received research funding for clinical studies on osteoarthritis, including studies of glucosamine/chondroitin by Galapagos, GSK, IBSA, Rottapharm and Servier and has been reimbursed for attending conferences where results have been presented.